Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadruple Immunosuppression with Everolimus in Sensitized Kidney Transplant
NCT06584773Phase 4Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Jun 2015
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in kidney transplant rejection, cytomegalovirus infection (CMV), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Jun 2015; status: recruiting.
02
Drugs
everolimus
03
Conditions
kidney transplant rejectioncytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT06584773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06584773.